Clinical Trial to Assess the Efficacy of µSmin® Plus

µSmin® Plus is a new Micronized Diosmin Formulation for oral administration. Diosmin is extremely well tolerated and safe to use. Diosmin is safe for most people when used short-term for up to 6 months. During the 8 weeks of the clinical investigation, the subject will administer 1 tablet of µSMIN® Plus (corresponding to 450 mg of micronized diosmin) or placebo per day.

It will be supplied by the Sponsor in an amount enough for the duration of the study. The subject will administer 1 tablet per day